PECAM-1 GENE POLYMORPHISM (rs668) AND SUBCLINICAL
MARKERS OF CAROTID ATHEROSCLEROSIS IN PATIENTS
WITH TYPE 2 DIABETES MELLITUS
Popović D, Nikolajević Starčević J, Šantl Letonja M, Makuc J,
Cokan Vujkovac A, Reschner H, Bregar D, Petrovič D
*Corresponding Author: Professor Daniel Petrovič, M.D., Ph.D., Institute of Histology and Embryology,
Faculty of Medicine University Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia. Tel: +386-1-543-7367.
Fax: +386-1-543-7361. E-mail: daniel.petrovic@mf.uni-lj.si
page: 63
|
|
REFERENCES
1. Cybulsky MI, Gimbrone MA. Endothelial expression
of a mononuclear leukocyte adhesion
molecule during atherogenesis. Science. 1991;
251(4995): 788-791.
2. Peter K, Nawroth P, Conradt C, Nordt T, Weiss
T, Boehme M, et al. Circulating vascular cell
adhesion molecule-1 correlates with the extent of
human atherosclerosis in contrast to circulating
intercellular adhesion molecule-1, E-selectin,
P-selectin, and thrombomodulin. Arterioscler
Thromb Vasc Biol. 1997; 17(3): 505-512.
3. Hwang S-J, Ballantyne CM, Sharrett AR, Smith
LC, Davis CE, Gotto AM Jr, et al. Circulating
adhesion molecules VCAM-1, ICAM-1, and Eselectin
in carotid atherosclerosis and incident
coronary heart disease cases. The Atherosclerosis
Risk In Communities (ARIC) Study. Circulation.
1997; 96(12): 4219-4225.
4. Rohde LE, Lee RT, Rivero J, Jamacochian M,
Arroyo LH, Briggs W, et al. Circulating cell adhesion
molecules are correlated with ultrasoundbased
assessment of carotid atherosclerosis.
Arterioscler Thromb Vasc Biol. 1998; 18(11):
1765-1770.
5. Albelda SM, Oliver PD, Romer LH, Buck CA.
EndoCAM: A novel endothelial cell-cell adhesion
molecule. J Cell Biol. 1990; 110(4): 1227-
1237.
6. Newman PJ, Berndt MC, Gorski J, White GC
2nd, Lyman S, Paddock C, et al. PECAM-1
(CD31) cloning and relation to adhesion molecules
of the immunoglobulin gene superfamily.
Science. 1990; 247(4947): 1219-1222.
7. Cicmil M, Thomas JM, Sage T, Barry FA, Leduc
M, Bon C, et al. Collagen, convulxin, and thrombin
stimulate aggregation-independent tyrosine
phosphorylation of CD31 in platelets. Evidence
for the involvement of Src family kinases. J Biol
Chem. 2000; 275(35): 27339-27347.
8. Falati S, Patil S, Gross PL, Stapleton M, Merrill-
Skoloff G, Barrett NE, et al. Platelet PECAM-1
inhibits thrombus formation in vivo. Blood.
2006; 107(2): 535-541.
9. Matsumura T, Wolff K, Petzelbauer P. Endothelial
cell tube formation depends on cadherin 5
and CD31 interactions with filamentous actin. J
Immunol. 1997; 158(7): 3408-3416.
10. Breier G, Breviario F, Caveda L, Berthier R,
Schnüch H, Gotsch U, et al. Molecular cloning
and expression of murine vascular endothelialcadherin
in early stage development of cardiovascular
system. Blood. 1996; 87(2): 630-641.
11. Piali L, Albelda SM, Baldwin HS, Hammel P,
Gisler RH, Imhof BA. Murine platelet endothelial
cell adhesion molecule (PECAM-1)/CD31
modulates beta 2 integrins on lymphokine-activated
killer cells. Eur J Immunol. 1993; 23(10):
2464-2471.
12. Newton-Nash DK, Newman PJ. A new role for
platelet-endothelial cell adhesion molecule-1
(CD31): inhibition of TCR-mediated signal transduction.
J Immu-nol. 1999; 163(2): 682-688.
13. Duncan GS, Andrew DP, Takimoto H, Kaufman
SA, Yoshida H, Spellberg J, et al. Genetic evidence
for functional redundancy of platelet/endothelial
cell adhesion molecule-1 (PECAM-1):
CD31-deficient mice reveal PECAM-1-dependent
and PECAM-1-independent func-tions. J
Immunol. 1999; 162(5): 3022-3030.
14. Behar E, Chao NJ, Hiraki DD, Krishnaswamy
S, Brown BW, Zehnder JL, et al. Polymorphism
of adhesion molecule CD31 and its role in acute
graft-versus-host disease. N Engl J Med. 1996;
334(5): 286-291.
15. Muller WA, Weigl SA, Deng X, Phillips DM.
PECAM-1 is required for transendothelial migration
of leukocytes. J Exp Med. 1993; 178(2):
449-460.
16. Sun J, Williams J, Yan HC, Amin KM, Albelda
SM, DeLisser HM. Platelet endothelial cell
adhesion molecule-1 (PECAM-1) homophilic
adhesion is mediated by immunoglobulin-like
domains 1 and 2 and depends on the cytoplasmic
domain and the level of surface expression. J
Biol Chem. 1996; 271(31): 18561-18570.
17. Reschner H, Milutinovič A, Petrovič D. The PECAM-
1 gene polymorphism – A genetic marker
of myocardial infarction. Cent Eur J Biol. 2009;
4(4): 515-520.
18. Wenzel K, Baumann G, Felix SB. The homozygous
combination of Leu125Val and Ser563Asn
polymorphisms in the PECAM1 (CD31) gene
is associated with early severe coronary heart
disease. Hum Mutat. 1999; 14(6): 545.
19. Gardemann A, Knapp A, Katz N, Tillmanns H,
Haberbosch W. No evidence for the CD31 C/G
gene polymorphism as an independent risk factor
of coronary heart disease. Thromb Haemost.
2000; 83(4): 629.
20. Sasaoka T, Kimura A, Hohta SA, Fukuda N,
Kurosawa T, Izumi T. Polymorphisms in the
platelet-endothelial cell adhesion molecule-1
(PECAM-1) gene, Asn563 Ser and Gly670Arg,
associated with myocardial infarction in the
Japanese. Ann NY Acad Sci. 2001; 947: 259-
269; discussion 269-270.
21. Wei H, Fang L, Chowdhury SH, Gong N, Xiong
Z, Song J, et al. Platelet-endothelial cell adhesion
molecule-1 gene polymorphism and its soluble
level are associated with severe coronary artery
stenosis in Chinese Singaporean. Clin Biochem.
2004; 37(12): 1091-1097.
22. Fleming I, Fisslthaler B, Dixit M, Busse R. Role
of PECAM-1 in the shear-stress-induced activation
of Akt and the endothelial nitric oxide
synthase (eNOS) in endothelial cells. J Cell Sci.
2005; 118(Pt 18): 4103-4111.
23. Bagi Z, Frangos JA, Yeh JC, White CR, Kaley
G, Koller A. PECAM-1 mediates NO-dependent
dilation of arterioles to high temporal gradients
of shear stress. Arterioscler Thromb Vasc Biol.
2005; 25(8): 1590-1595.
24. DeBakey ME, Lawrie GM, Glaeser DH. Patterns
of atherosclerosis and their surgical significance.
Ann Surg. 1985; 201(2): 115-131.
25. Bao X, Lu C, Frangos JA. Temporal gradient in
shear but not steady shear stress induces PDGFA
and MCP-1 expression in endothelial cells:
role of NO, NF kappa B, and egr-1. Arterioscler
Thromb Vasc Biol. 1999; 19(4): 996-1003.
26. American Diabetes Association. Diagnosis and
Classification of Diabetes Mellitus. Diabetes
Care. 2012; 35(Suppl 1): S64-S71 (http://dx.doi.
org/10.2337/dc12-s064).
27. Serebruany VL, Murugesan SR, Pothula A, Atar
D, Lowry DR, O’Connor CM, et al. Increased
soluble platelet/endothelial cellular adhesion
molecule-1 and osteonectin levels in patients
with severe congestive heart failure. Independence
of disease etiology, and antecedent aspirin
therapy. Eur J Heart Fail. 1999; 1(3): 243-249.
28. Shalia KK, Mashru MR, Soneji SL, Shah VK,
Payannavar S, Walvalkar A, et al. Leucine-
125Valine (Leu 125Val) gene polymorphism
of platelet endothelial cell adhesion molecule-1
(PECAM-1) and myocardial infarction in Indian
Population. Ind J Clin Biochem. 2010; 25(3):
273-279.
29. Fang L, Wei H, Chowdhury SH, Gong N, Song J,
Heng CK, et al. Association of Leu125Val polymorphism
of platelet endothelial cell adhesion
molecule-1 (PECAM-1) gene & soluble level of
PECAM-1 with coronary artery disease in Asian
Indians. Indian J Med Res. 2005; 121(2): 92-99.
30. Listi F, Caruso C, Di Carlo D, Falcone C, Boiocchi
C, Cuccia M, et al. Association between
platelet endothelial cellular adhesion molecule-1
polymorphisms and atherosclerosis: results of a
study on patients from northern Italy. Rejuvenation
Res. 2010; 13(2-3): 237-241.
31. Xia T, Liu X, Jiang CD, Jin X, Kong XQ, Li G.
Association of Leu125Val polymorphisms in the
PECAM-1 gene with the risk of coronary heart
disease: a meta-analysis. Int J Clin Exp Med.
2015; 8(2): 2219-2225. 32. Moreno PR, Fuster V. New aspects in the pathogenesis
of diabetic atherothrombosis. J Am Coll
Cardiol. 2004; 44(12): 2293-2300.
33. Grundy SM, Benjamin IJ, Burke GL, Chait A,
Eckel RH, Howard BV, et al. Diabetes and cardiovascular
disease: a statement for healthcare
professionals from the American Heart Association.
Circulation. 1999; 100(10): 1134-1146.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
